AGL 38.56 Decreased By ▼ -0.77 (-1.96%)
AIRLINK 207.77 Increased By ▲ 17.83 (9.39%)
BOP 10.06 Increased By ▲ 0.55 (5.78%)
CNERGY 7.08 Decreased By ▼ -0.04 (-0.56%)
DCL 9.99 Decreased By ▼ -0.23 (-2.25%)
DFML 41.14 Decreased By ▼ -0.54 (-1.3%)
DGKC 103.46 Decreased By ▼ -6.36 (-5.79%)
FCCL 36.35 Decreased By ▼ -1.81 (-4.74%)
FFBL 91.59 Decreased By ▼ -4.67 (-4.85%)
FFL 14.60 Decreased By ▼ -0.29 (-1.95%)
HUBC 139.43 Increased By ▲ 10.60 (8.23%)
HUMNL 14.10 Decreased By ▼ -0.42 (-2.89%)
KEL 5.97 Decreased By ▼ -0.22 (-3.55%)
KOSM 7.86 Decreased By ▼ -0.13 (-1.63%)
MLCF 47.28 Decreased By ▼ -2.70 (-5.4%)
NBP 73.76 Increased By ▲ 1.33 (1.84%)
OGDC 222.66 Decreased By ▼ -10.63 (-4.56%)
PAEL 38.11 Increased By ▲ 2.99 (8.51%)
PIBTL 9.27 Decreased By ▼ -0.09 (-0.96%)
PPL 205.85 Decreased By ▼ -5.55 (-2.63%)
PRL 39.85 Increased By ▲ 3.33 (9.12%)
PTC 26.62 Increased By ▲ 0.58 (2.23%)
SEARL 110.24 Decreased By ▼ -4.56 (-3.97%)
TELE 9.23 Decreased By ▼ -0.18 (-1.91%)
TOMCL 38.21 Decreased By ▼ -0.39 (-1.01%)
TPLP 13.77 Increased By ▲ 0.98 (7.66%)
TREET 26.45 Increased By ▲ 0.47 (1.81%)
TRG 60.54 Decreased By ▼ -1.46 (-2.35%)
UNITY 34.14 Decreased By ▼ -1.43 (-4.02%)
WTL 1.88 Decreased By ▼ -0.04 (-2.08%)
BR100 12,299 No Change 0 (0%)
BR30 38,877 No Change 0 (0%)
KSE100 114,861 No Change 0 (0%)
KSE30 36,196 No Change 0 (0%)

KARACHI: Jinnah Postgraduate Medical Centre (JPMC) is going to utilise its cancer treatment service to the optimum level as the state of the art multi-million dollar Tomotherapy machine would now serve up to 65 cancer patients, on a daily basis.

Department of Psychiatry & Behavioural Sciences at JPMC would be enhanced four times by March 2022, and the gynaecology department would also be revamped by the end of next year.

Patients’ Aid Foundation (PAF)-JPMC Executive Committee Chairman Mushtaq K Chhapra told Business Recorder that PAF-JPMC has been able to introduce latest radiographic equipment at JPMC, one such equipment is Tomotherapy which has been serving patients since October last year.

“Around 25 cancer patients are currently being served free of cost through Tomotherapy system, per day. However, in order to cater the growing needs of patients, we have decided to utilise this technology to its optimum level,”

We have extensively worked towards enhancing and upgrading radiographic facilities at JPMC. The Tomotherapy System is among the most revolutionary radiotherapy innovations in the history of cancer treatment, completely redefining the standard for individualised and precise treatment of tumours anywhere in the body — while creating a new paradigm for patient comfort and quality of life.

He said the CyberKnife technology at JPMC also serves approx 25 patients per day. JPMC is the only hospital in Pakistan offering this treatment and the only hospital in the world providing it free of cost. The actual cost for one treatment internationally goes up to $1,000, he said.

CyberKnife Robotic Radiosurgery, a robotic cutting edge technology, uses high cancer killing dose of radiation in a precise, painless, and non-invasive manner.

Chhapra said that Cancer treatment puts a great financial stress on needy patients, many of the affected patients are not able to get timely treatment and many have to leave the treatment in between due to their financial shortcomings. Cancer is the leading cause of death in Pakistan, by the end of 2020, new cancer cases estimated to be 180,000 and recorded cancer deaths were approximately with 330,000 prevalent cases in the last 5 years.

He said PAF-JPMC have already initiated the construction for Department of Psychiatry and Behavioural Sciences at JPMC to provide quality mental health services free of charge to deserving patients. He said that socio-economic adversities, poverty, strained family relations etc. have contributed to the psychological problems in Pakistan, especially in our masses. A very small percentage of psychiatric units are state-owned which further amplifies the mental problems of the less privileged classes.

Copyright Business Recorder, 2021

Comments

Comments are closed.